Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles HIV Medicine Year : 2021

Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

Firouzé Bani‐sadr
Karine Lacombe
Laure Esterle
Camille Gilbert
  • Function : Author
Patrick Miailhes
  • Function : Author
David Zucman
Marc Antoine Valantin
  • Function : Author
Sylvie Brégigeon‐ronot
  • Function : Author
Philippe Morlat
  • Function : Author
Eric Billaud
  • Function : Author
Lionel Piroth
  • Function : Author
Alissa Naqvi
  • Function : Author
Philippe Sogni
  • Function : Author
Dominique Salmon
  • Function : Author
Not file

Dates and versions

hal-03534087 , version 1 (19-01-2022)

Identifiers

Cite

Mathieu Chalouni, Linda Wittkop, Firouzé Bani‐sadr, Karine Lacombe, Laure Esterle, et al.. Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Medicine, 2021, 22 (9), pp.791-804. ⟨10.1111/hiv.13127⟩. ⟨hal-03534087⟩
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More